Indian equity benchmark indices are likely to open on a flat note on Friday, tracking mixed global cues and subdued overnight market signals. Domestic trading resumes after a holiday on Thursday, when the BSE and NSE remained closed due to municipal corporation elections in Maharashtra.
Several stocks are likely to remain in focus during today’s session due to sectoral developments, corporate actions, and quarterly updates.
Stocks to watch today
• Infosys: Constant currency revenue growth at 0.6% QoQ versus expectation of flat growth; guidance raised.
• Sun Pharmaceutical Industries: Announced US availability of Unloxcyt carcinoma treatment.
• Godrej Properties: 9MFY26 sales up 25%; collections increased 19% year-on-year.
• Angel One: Reported an operationally strong quarter; performance ahead of estimates.
• Prestige Group: Q3 pre-sales rose 39%; collections up 40% YoY.
• 360 ONE WAM: Profit increased 20% YoY; revenue grew 33% YoY.
• ICICI Prudential AMC: Strong quarter; QAAUM growth faster than industry average of 5%.
• Restaurant Brands Asia: Board meeting scheduled on January 20 to consider fundraising.
• Oil Marketing Companies: Brent crude slips below $64 per barrel, potentially supportive for near-term margins.
• Transrail Lighting: Secured orders worth ₹527 crore across MENA, Africa and India.
• Bharat Heavy Electricals: Commenced supply of underslung traction transformers for Vande Bharat sleeper trains.
• Zen Technologies: Bagged defence orders worth ₹404 crore from the Ministry of Defence.
• Waaree Renewable Technologies: Revenue up 2.4x YoY; EBITDA up 2.2x; margin at 18.6% versus 19.8% last year.
• Indian Hotels Company: To acquire 51% stake in Brij Hospitality for ₹225 crore; portfolio includes 22 hotels, 11 operational.
• Zydus Lifesciences: Received final US FDA approval for a blood disorder drug with market size of $1,263 million.
• Kernex Microsystems: Won KAVACH project order worth ₹2,466 crore.
• Nuvoco Vistas: Q3 performance broadly in line; management commentary remains optimistic.
• HDFC Life Insurance: New business premium missed estimates; VNB margin slightly higher at 24%.
• L&T Technology Services: Q3 miss due to business recalibration; constant currency revenue down 2.8% QoQ.
• Cipla: Temporarily paused manufacturing of one of its key drugs, Lanreotide.
• Sterling and Wilson Renewable Energy: Revenue up 70% YoY; EBITDA declined 79% YoY.
• HDB Financial Services: Credit costs remain above the normal range of 2%.
• Kolte-Patil Developers: Q3 sales value declined 11%; sales volume down 14% YoY.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.